| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |